Goldman Sachs initiates coverage on Medivation (NASDAQ: MDVN) with a Buy rating and $68 price target, suggesting 28% upside.

This article: 145 words
-->

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE